Beth Faiman:
You might have heard of CAR T-cell therapy, but who's a candidate? Hi, my name is Beth Faiman. I am on the International Myeloma Foundation's Nurse Leadership Board, and I'm here to talk to you about CAR T-cell therapy in a minute or less.
So, CAR T-cell therapy is a very innovative therapy that has proved to be very effective for many patients with myeloma. You can have CAR T-cell therapy if you've had one prior line of therapy including with bortezomib or Velcade and lenalidomide or an immunomodulatory drug. It's really important to know if you're a candidate or not and then seek the information. Other important factors are your organ function, kidney, liver, heart in order to withstand the procedure, and also your disease characteristics. If you have rapidly dividing myeloma cells and active myeloma, you might not do as well, so we need to get you in remission first.
So if you are wondering if you're a candidate for CAR T-cell therapy, talk to your healthcare provider. Seek out a CAR T-cell therapy center and have that discussion to find out if CAR T-cell therapy might be right for you.
